Skip to content
Dose Brief
Menu
No. 56 on the board · Grade C

Peter MD review

A Miami telehealth desk (physician-prescribed, founded 2021) running TRT, ED, weight loss, GLP-1, hair loss and NAD+ on one account — with published per-treatment prices, though the two GLP-1 lines are billed in tiers rather than one flat monthly rate.

Visit Peter MD Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$149/mo new-user tier · $139/mo returning-user tier (GLP1 + B12)
Tirzepatide
$249/mo after a $149 first month (billed quarterly, 60mg)
Coverage
Most states — exclusions vary by treatment (not a single list)
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior reading— First reading, 2026-08-04: tirzepatide runs $149 the first month before resetting to $249 on quarterly billing; compounded semaglutide (sold as GLP1 + B12) splits into a $149/mo new-user tier and a $139/mo returning-user tier rather than one flat monthly rate.

The scorecard

Peter MD scored on our six Brief Score factors. See the methodology.

Price Stability76/100
Supply Reliability82/100
Transparency65/100
Access Breadth78/100
Clinical Oversight82/100
Track Record74/100

What we like

  • Broad catalog on one account — tirzepatide, compounded semaglutide, TRT, sermorelin, NAD+, men's hair loss and ED — rather than a single-molecule program
  • Real prices published on the product pages themselves for every line (tirzepatide, semaglutide, sermorelin, NAD+, TRT) — nothing gated behind a quiz to see a number
  • TRT priced flat at $79/mo on a 12-month plan, and NAD+ and sermorelin both published with a total-supply cost, not just a teaser rate
  • Physician-prescribed telehealth model with broad, nationwide-leaning reach

The caveats

  • Neither GLP-1 line is a flat monthly rate: tirzepatide steps up from $149 to $249 after month one, and semaglutide splits into new-user ($149/mo, ~$447 total) and returning-user ($139/mo, ~$834 total) tiers whose totals don't scale cleanly off the monthly figure — a tiered ladder, not a per-dose price
  • State coverage is genuinely two different lists: the customer-facing pages name only AL/ID (or AL/ID/AK/HI for semaglutide) as excluded, but the affiliate program's own sheet excludes several more states depending on the specific treatment (B-12, HCG and tirzepatide each carry their own exclusions) — confirm your state AND your treatment before signing up
  • Semaglutide is sold compounded with B12 rather than as a standalone product, and no GLP-1 line here is FDA-approved
  • Customer reviews are mixed

The brief

Best for: Readers who want GLP-1 care bundled with TRT, sermorelin, NAD+ or hair-loss treatment on a single account, and are comfortable reading a tiered price ladder rather than one flat monthly figure this site can map straight onto a dose. A Miami telehealth desk (physician-prescribed, founded 2021) running TRT, ED, weight loss, GLP-1, hair loss and NAD+ on one account — with published per-treatment prices, though the two GLP-1 lines are billed in tiers rather than one flat monthly rate.

Ranked #56 of 497 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Visit Peter MD

Closest on the board

The desks scoring nearest Peter MD — the realistic shortlist if you're weighing it.

Weighing Peter MD against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs Peter MD, and every desk that outranks it is listed on the Peter MD alternatives board.

More desks we track (24)

466 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect Peter MD's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Peter MD's site. Not medical advice; see our disclosure.

← Back to all rankings